These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33645482)

  • 1. Predicted SARS-CoV-2 miRNAs Associated with Epigenetic Viral Pathogenesis and the Detection of New Possible Drugs for Covid-19.
    Çetin Z; Bayrak T; Oğul H; Saygılı Eİ; Akkol EK
    Curr Drug Deliv; 2021; 18(10):1595-1610. PubMed ID: 33645482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFI44 is an immune evasion biomarker for SARS-CoV-2 and
    Zheng Q; Wang D; Lin R; Lv Q; Wang W
    Front Immunol; 2022; 13():1013322. PubMed ID: 36189314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach.
    Roy S; Sharma B; Mazid MI; Akhand RN; Das M; Marufatuzzahan M; Chowdhury TA; Azim KF; Hasan M
    Comput Biol Med; 2021 Jul; 134():104451. PubMed ID: 34020131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.
    Sarma A; Phukan H; Halder N; Madanan MG
    Comput Biol Chem; 2020 Oct; 88():107352. PubMed ID: 32771962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
    Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
    BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.
    Saçar Demirci MD; Adan A
    PeerJ; 2020; 8():e9369. PubMed ID: 32547891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edible plant-derived exosomal microRNAs: Exploiting a cross-kingdom regulatory mechanism for targeting SARS-CoV-2.
    Kalarikkal SP; Sundaram GM
    Toxicol Appl Pharmacol; 2021 Mar; 414():115425. PubMed ID: 33516820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
    Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
    Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.
    Rahaman M; Komanapalli J; Mukherjee M; Byram PK; Sahoo S; Chakravorty N
    Comput Biol Med; 2021 Sep; 136():104669. PubMed ID: 34320442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of predicted miRNA between Indonesia and China (Wuhan) SARS-CoV-2: a bioinformatics analysis.
    Rahmadi A; Fasyah I; Sudigyo D; Budiarto A; Mahesworo B; Hidayat AA; Pardamean B
    Genes Genomics; 2021 Sep; 43(9):1079-1086. PubMed ID: 34152577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
    Khan MA; Sany MRU; Islam MS; Islam ABMMK
    Front Genet; 2020; 11():765. PubMed ID: 32765592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection.
    Zhang S; Amahong K; Zhang C; Li F; Gao J; Qiu Y; Zhu F
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34585235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.
    Ahmed JQ; Maulud SQ; Dhawan M; Priyanka ; Choudhary OP; Jalal PJ; Ali RK; Tayib GA; Hasan DA
    J Infect Public Health; 2022 Jul; 15(7):788-799. PubMed ID: 35751930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?
    Guterres A; de Azeredo Lima CH; Miranda RL; Gadelha MR
    Infect Genet Evol; 2020 Nov; 85():104417. PubMed ID: 32526370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.
    Meng F; Siu GK; Mok BW; Sun J; Fung KSC; Lam JY; Wong NK; Gedefaw L; Luo S; Lee TMH; Yip SP; Huang CL
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.
    Bhavya ; Pathak E; Mishra R
    J Endocrinol Invest; 2022 Mar; 45(3):537-550. PubMed ID: 34669152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
    Pierce JB; Simion V; Icli B; Pérez-Cremades D; Cheng HS; Feinberg MW
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33207533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico analysis of genomic landscape of SARS-CoV-2 and its variant of concerns (Delta and Omicron) reveals changes in the coding potential of miRNAs and their target genes.
    Saini S; Khurana S; Saini D; Rajput S; Thakur CJ; Singh J; Jaswal A; Kapoor Y; Kumar V; Saini A
    Gene; 2023 Feb; 853():147097. PubMed ID: 36470485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.
    Yousefi H; Poursheikhani A; Bahmanpour Z; Vatanmakanian M; Taheri M; Mashouri L; Alahari SK
    Biomed Pharmacother; 2020 Oct; 130():110548. PubMed ID: 33475497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.